STUDY OF THE PHARMACOLOGICAL ACTIVITY OF NOVEL EPOR/CD131 HETERORECEPTOR AGONISTS IN MICE WITH ENDOTHELIAL-SPECIFIC EXPRESSION OF MUTANT POLG GENE

STUDY OF THE PHARMACOLOGICAL ACTIVITY OF NOVEL EPOR/CD131 HETERORECEPTOR AGONISTS IN MICE WITH ENDOTHELIAL-SPECIFIC EXPRESSION OF MUTANT POLG GENE

The aim of the research was to study antiatherosclerotic and endothelial kinds of a protective activity of peptides mimicking an erythropoietin a-helix B tertiary structure with laboratory codes EP-11-1 (UEHLERALNSS), EP-11-2. (UEQLERALNCS), EP-11-3 (UEQLERALNTS).Materials and methods. The study was...

Full description

Bibliographic Details
Main Authors: М. В. Korokin, M. V. Kubekina, A. V. Deykin, O. V. Antsiferov, V. M. Pokrovskii, L. V. Korokina, N. L. Kartashkina, V. A. Soldatova, E. V. Kuzubova, A. I. Radchenko, M. V. Pokrovskii
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2021-09-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
atherosclerosis
erythropoietin derivatives
phbsp derivatives
atheroprotective effect
endothelial protective effect
Online Access:https://www.pharmpharm.ru/jour/article/view/880

Internet

https://www.pharmpharm.ru/jour/article/view/880

Similar Items